<PAGE>
FORM 12b-25 SEC File Number 0-14025
CUSIP Number 126844-10-9
NOTIFICATION OF LATE FILING
(Check One)
(X) Form 10-K ( ) Form 11-K ( ) Form 20-F (X) Form 10-Q
For Period Ended: June 30, 1997
______________________________________________________________________
Read Attached Instruction Sheet Before Preparing Form.
Please Print or Type.
Nothing in this form shall be construed to imply that the
Commission has verified any information contained herein.
______________________________________________________________________
If the notification relates to a portion of the filing checked
above, identify the Item(s) to which the notification relates:
Not Applicable.
______________________________________________________________________
Part I -- Registrant Information
- ----------------------------------------------------------------------
Full Name of Registrant: Verex Laboratories, Inc.
Former Name if Applicable: N/A
______________________________________________________________________
Address of Principal Executive Office (Street and Number):
Bldg. D., Suite 100, 14 Inverness Drive East
______________________________________________________________________
City, State and Zip Code: Englewood, Colorado 80112
______________________________________________________________________
Part II -- Rules 12b-25 (b) and (c)
- ----------------------------------------------------------------------
If the subject report could not be filed without unreasonable
effort or expense and the registrant seeks relief pursuant to Rule
12b-25(b), the following should be completed. (Check box if
appropriate).
[ ] (a) The reasons described in reasonable detail in Part III
of this form could not be eliminated without
unreasonable effort or expense;
[X] (b) The subject annual report/portion thereof will be filed
on or before the fifteenth calendar day following the
prescribed due date; or the subject quarterly
report/portion thereof will be filed on or before the
fifth calendar day following the prescribed due date;
and
[ ] (c) The accountant's statement or other exhibit required by
Rule 12b-25(c) has been attached if applicable.
<PAGE>
______________________________________________________________________
Part III -- Narrative
- ----------------------------------------------------------------------
State below in reasonable detail the reasons why the Form 10-K,
11-K, 20-F or 10-Q or portion thereof could not be filed within
the prescribed time period.
Delays in obtaining preliminary auditors report due to post
year-end adjustments and related matters.
______________________________________________________________________
Part IV -- Other Information
- ----------------------------------------------------------------------
(1) Name and telephone number of person to contact in regard to
this notification:
James M. Dunn, M.D. 303 799-4499
----------------------------------------------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required
(under Section 13 or 15(d) of the
Securities Exchange Act of 1934) during [X] Yes [ ] No
the preceding 12 months (or for such
shorter period that the registrant was
required to file such reports) been filed?
If answer no identify report(s).
(3) Is it anticipated that any significant
change in results of operations from the
corresponding period for the last fiscal [ ] Yes [X] No
year will be reflected by the earnings
statements to be included in the subject
report or portion thereof?
If so: attach an explanation of the
anticipated change, both narratively and
quantitatively, and, if appropriate, state
the reasons why a reasonable estimate of
the results cannot be made.
<PAGE>
Verex Laboratories, Inc.
--------------------------------------------
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the
undersigned thereunto duly authorized.
BY(Signature) /s/ James M. Dunn, M.D.
(Date) September 25, 1997
(Name and Title) James M. Dunn, M.D., President